Rate of Re-excision after Breast-conserving Surgery for Invasive Lobular Carcinoma

Invasive lobular carcinoma (ILC) accounts for approximately 5 to 20 per cent of all breast cancers and is often multicentric. Despite pre- and intraoperative assessments to achieve negative margins, ILC is reported to be associated with higher rates of positive margin. This cross-sectional study examined patients with breast cancer treated at our institution from 2000 to 2010. The objective was to investigate the rate of re-excision resulting from positive or close margin (1 mm or less) in patients who underwent breast-conserving surgery (BCS) for ILC compared with invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS). Of the 836 patients treated, 416 patients underwent BCS. The rate of re-excision after BCS for ILC was 35.1 versus 17.7 per cent for IDC and 20.0 per cent for DCIS (P = 0.04). Re-excisions were more often performed for positive margin in patients with ILC (11 of 37 [29.7%]) versus IDC (36 of 334 [10.8%]) and DCIS (five of 45 [11.1%];(P = 0.004). In this single-institution review, BCS for ILC had significantly higher rates of re-excision as a result of positive margins when compared with IDC and DCIS. Tumor size greater than 2 cm and lymph node involvement were identified as factors associated with positive surgical margin in ILC. The higher possibility of positive margins and the need for additional procedures should be discussed with patients undergoing BCS for ILC.

[1]  S. Duffy,et al.  Reduction in rate of node metastases with breast screening: consistency of association with tumor size , 2013, Breast Cancer Research and Treatment.

[2]  R. Mann The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast. , 2010, Magnetic resonance imaging clinics of North America.

[3]  A. Hanby,et al.  In situ and invasive lobular neoplasia of the breast , 2007, Histopathology.

[4]  Ritse M. Mann,et al.  MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature , 2007, Breast Cancer Research and Treatment.

[5]  V. Beral,et al.  Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. , 2006, The Lancet. Oncology.

[6]  H. Kuerer,et al.  Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. , 2006, American journal of surgery.

[7]  D. Scholtens,et al.  Selecting patients for breast‐conserving therapy , 2006, Cancer.

[8]  P. Bult,et al.  Mammographic detection and staging of invasive lobular carcinoma. , 2006, Clinical imaging.

[9]  G. Divine,et al.  E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. , 2006, American journal of clinical pathology.

[10]  L. Solin,et al.  Similar long‐term results of breast‐conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast , 2005, Cancer.

[11]  A. Hanby,et al.  Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy , 2005, British Journal of Cancer.

[12]  E. Stickeler,et al.  Ultrasound morphology of invasive lobular breast cancer is different compared with other types of breast cancer. , 2005, Ultrasound in medicine & biology.

[13]  B. Anderson,et al.  Trends in incidence rates of invasive lobular and ductal breast carcinoma. , 2003, JAMA.

[14]  J. Imbrie,et al.  Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. , 2000, Annals of surgery.

[15]  T. Yeatman,et al.  Tumor Biology of Infiltrating Lobular Carcinoma: Implications for Management , 1995, Annals of surgery.

[16]  F. Vicini,et al.  Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast: The role of preoperative mammograms in guiding treatment , 1994, Cancer.

[17]  M. Silverstein,et al.  Infiltrating lobular carcinoma: Is it different from infiltrating duct carcinoma? , 1994, Cancer.

[18]  A. Giuliano,et al.  Conservation therapy for invasive lobular carcinoma of the breast , 1992, Cancer.

[19]  M. Lesser,et al.  Multicentricity and bilaterality in invasive breast carcinoma. , 1982, Surgery.

[20]  C. Redmond,et al.  Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer , 1975, Cancer.

[21]  F. W. Foote,et al.  COMPARATIVE STUDIES OF CANCEROUS VERSUS NONCANCEROUS BREASTS , 1945, Annals of surgery.

[22]  S. Jaffer,et al.  Chapter 9 – Pathology of Invasive Breast Cancer , 2005 .

[23]  T Kumazaki,et al.  Radiographic features of invasive lobular carcinoma of the breast. , 2001, Radiation medicine.

[24]  R. Millis Infiltrating Lobular Carcinoma , 1984 .